drugset / Trial / NCT02447497

In Vivo Patient Preoperative Skin Prep Persistence

NCT02447497

Phase 2 Completed 27 enrolled Solventum US LLC 3M · collab
RandomizedParallel-groupSingle-blindPrevention

Summary

The objective of the study is to demonstrate persistence of the CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.

Timeline

Start
2015-03
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine gluconate Other / unclassified 2 % Topical
Subject Isopropyl alcohol Other / unclassified 70 % Topical

Indications

No indication recorded.